Quantcast

Latest Diagnostic test Stories

2014-07-15 23:14:13

North American Seminars provides pre-approved course that can be used for re-licensure for physical therapists and physical therapy assistants in California and Nevada. Examination and Treatment of the Hip Joint, a PT Online Continuing Education Course from Healthclick has been pre-approved for 10 hrs for PT & PTA's licensed in CA and NV. Franklin, TN (PRWEB) July 15, 2014 Examination and Treatment of the Hip Joint is an online physical therapy continuing education course...

2014-07-10 12:30:06

TUCSON, Ariz., July 10, 2014 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced it has entered into an agreement with Merck KGaA, Darmstadt, Germany, which operates as EMD Serono in the United States and Canada, to collaborate with Merck KGaA's biopharmaceutical division on the development and commercialization of a companion diagnostic (CDx) for an undisclosed target using Ventana's proprietary diagnostic assays. In alignment with...

2014-06-24 08:29:45

Future revisions to in-vitro diagnostics laws will offset the launch of new tests, in a market expected to soar to $1,295.1 million in 2018 LONDON, June 24, 2014 /PRNewswire/ -- With the growth in personalised medicine, there is an increased interest in developing companion diagnostics (CDx) tests or tests that match the right therapy to the patient. In fact, over the past few years, market participants have been entering pharmaceutical and diagnostic partnerships in a bid to develop...

2014-06-16 08:28:21

MADISON, N.J. and SAN DIEGO, June 16, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, and Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced an agreement under which Quest will offer national access to Sequenom Laboratories' MaterniT21(TM) PLUS laboratory-developed test (LDT). Using a maternal blood sample, the noninvasive prenatal test (NIPT)...

2014-05-26 23:01:02

RnRMarketResearch.com adds “MediPoint: Companion Diagnostic Tests in Oncology – Global Analysis and Market Forecasts” to its store. Order a purchased copy @ http://www.rnrmarketresearch.com/contacts/purchase?rname=176910. Dallas, Texas (PRWEB) May 26, 2014 The major feature of the companion diagnostic testing market is the current domination of tests for mutations important in the prognosis and diagnosis of non-small cell lung cancer (NSCLC), with the two market leaders being Roche...

2014-05-20 08:34:42

Actor Announces Investment in Crowdsourced Medical Diagnosis Platform SAN FRANCISCO, May 20, 2014 /PRNewswire/ -- CrowdMed, an online crowdsourced medical diagnosis platform that helps solve even the world's most difficult medical cases, today announced that actor Patrick Dempsey has made an investment in the company. Almost one in 10 Americans - and 350 million people globally - are affected by the approximately 7,000 different types of rare or difficult-to-diagnose medical...

2014-05-20 08:33:17

NEW YORK, LONDON, BERLIN and PARIS, May 20, 2014 /PRNewswire/ -- SOURCE M/S. Reportstack

2014-04-03 12:28:49

TUCSON, Ariz., April 3, 2014 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced that it has entered into an agreement with Genmab A/S, Copenhagen, Denmark for the development of companion diagnostic tools for Genmab's HuMax-TF®-ADC antibody drug conjugate (ADC) program. As part of the agreement, Ventana will provide its expertise and services towards the development of an immunohistochemistry (IHC) companion diagnostic test for the...

2014-03-11 23:26:36

Unbiased Measure of Diagnostic Quality is Shared by Miraca Life Sciences Dallas, TX (PRWEB) March 11, 2014 Today, Miraca Life Sciences (MLS), the largest independent anatomical pathology lab in the United States, reported that they are now adopting a new benchmark to objectively measure the quality of anatomical pathology services and diagnostic accuracy. MLS announced that they will begin publishing their concordance rates with outside academic institutions as an unbiased measure of...

2014-03-11 08:29:02

NEW YORK, March 11, 2014 /PRNewswire/ -- Exosome Diagnostics today announced the initial close of its Series B financing round with the raising of $27 million. Proceeds will be used to advance development of the Company's proprietary platform technology and commercial programs for non-invasive, fluid-based molecular diagnostics in oncology, neurodegenerative diseases and other clinical areas. Key Points: -- Co-leading the financing were new investors QIAGEN and Arcus Ventures --...


Word of the Day
toccata
  • In music, a work for a keyboard-instrument, like the pianoforte or organ, originally intended to utilize and display varieties of touch: but the term has been extended so as to include many irregular works, similar to the prelude, the fantasia, and the improvisation.
This word is Italian in origin, coming from the feminine past participle of 'toccare,' to touch.
Related